CytoMed Therapeutics Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $157 | $189 | $168 | $205 |
Gross Profit | -2,048 | 165 | -2,451 | 173 |
EBITDA | -1,547 | -783 | -1,517 | -986 |
EBIT | -1,784 | -901 | -1,739 | -1,097 |
Net Income | -1,770 | -885 | -1,736 | -868 |
Net Change In Cash | 157 | 189 | 168 | 205 |
Free Cash Flow | -1,844 | -916 | -2,347 | -1,194 |
Cash | 1,457 | 1,458 | 2,095 | 2,095 |
Basic Shares | 11,880 | 11,880 | 11,647 | 11,754 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $324 | $69 | $509 | $365 |
Gross Profit | 256 | 52 | -4,361 | -109 |
EBITDA | -3,573 | -2,166 | -3,700 | -2,611 |
EBIT | -3,975 | -2,501 | -4,081 | -3,004 |
Net Income | -3,980 | -2,516 | -4,132 | -3,131 |
Net Change In Cash | 324 | 69 | 509 | 365 |
Free Cash Flow | -4,400 | -4,109 | -3,599 | -1,880 |
Cash | 2,095 | 4,969 | 9,019 | 1,587 |
Basic Shares | 11,647 | 11,539 | 10,630 | 7,915 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.19 |
2025-03-31 | -$0.12 |
2024-09-30 | -$0.04 |